Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Non-invasive Neuromodulation on Post-COVID-19 Syndrome: Multicenter Study

NCT06689345 is registered in ClinicalTrials.gov with Federal University of ABC as lead sponsor.

NCT NCT06689345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06689345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Non-invasive Neuromodulation on Post-COVID-19 Syndrome: Multicenter Study
Lead sponsor
Federal University of ABC
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 21, 2024
Completion date
December 16, 2024
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, healthy, post covid condition